Brind.

AstraZeneca conducted a clinical trial using Personalis' technology.

2 reports, 1 independent Updated Sep 4

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

AstraZeneca conducted a clinical trial using Personalis' technology.

Who's involved

What this event is mainly about

Personalis (United States)AstraZeneca

How it developed

Newest first. Tap a step to see who reported it.

Sep 4The trial was conducted on September 4, 2025.1 source
- Business Wire
Aug 6Collaboration between AstraZeneca and Personalis expands to include colorectal cancer indication and Phase 3 cervical cancer trial.1 source
- Business Wire

Keep exploring

The entities involved

Personalis (United States)
company in Menlo Park, United States

Nothing else this week.
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52

Related events

Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.Aug 28

Coverage

Newest first; wire copies grouped

Sep 4Business WirePersonalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing FREMONT, Calif., September 03, 2025--(BUSINESS WIRE)--Pe
Aug 6Business WirePersonalis Reports Second Quarter 2025 Financial Results Strong Q2 Clinical Momentum with 59% Sequential Growth in Test Volume FREMONT, Calif., August 05, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nas